Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Dicker

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Cancer Biology & Therapy|November 19, 2005
Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environmentPatrick A Mayes, Latoya Campbell, M Stacey Ricci, et al.
Neoplasia (New York, N.Y.)|February 14, 2021
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9Xiaobing Tian, Nagib Ahsan, Amriti Lulla, et al.
Neoplasia (New York, N.Y.)|November 15, 2025
Corrigendum to "P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9" [Neoplasia, volume 23 (2021) 304325]Xiaobing Tian, Nagib Ahsan, Amriti Lulla, et al.
Cancer Biology & Therapy|September 24, 2005
Acridine derivatives activate p53 and induce tumor cell death through BaxWenge Wang, William C Ho, David T Dicker, et al.
Oncology Letters|June 17, 2014
Detection of circulating tumor cells in the cerebrospinal fluid of a patient with a solitary metastasis from breast cancer: A case reportAkshal S Patel, Joshua E Allen, David T Dicker, et al.
The American Journal of Pathology|October 7, 2011
High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumorsNiklas K Finnberg, Lori S Hart, Nathan G Dolloff, et al.
Molecular and Cellular Biology|September 16, 2004
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivityM Stacey Ricci, Zhaoyu Jin, Michael Dews, et al.
Molecular Cancer|May 1, 2015
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cellsElizabeth M Matthew, Timothy J Yen, David T Dicker, et al.
Molecular Cancer|October 18, 2024
Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Cancer Biology & Therapy|November 19, 2005
Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environmentPatrick A Mayes, Latoya Campbell, M Stacey Ricci, et al.
Neoplasia (New York, N.Y.)|February 14, 2021
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9Xiaobing Tian, Nagib Ahsan, Amriti Lulla, et al.
Neoplasia (New York, N.Y.)|November 15, 2025
Corrigendum to "P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9" [Neoplasia, volume 23 (2021) 304325]Xiaobing Tian, Nagib Ahsan, Amriti Lulla, et al.
Cancer Biology & Therapy|September 24, 2005
Acridine derivatives activate p53 and induce tumor cell death through BaxWenge Wang, William C Ho, David T Dicker, et al.
Oncology Letters|June 17, 2014
Detection of circulating tumor cells in the cerebrospinal fluid of a patient with a solitary metastasis from breast cancer: A case reportAkshal S Patel, Joshua E Allen, David T Dicker, et al.
The American Journal of Pathology|October 7, 2011
High-resolution imaging and antitumor effects of GFP(+) bone marrow-derived cells homing to syngeneic mouse colon tumorsNiklas K Finnberg, Lori S Hart, Nathan G Dolloff, et al.
Molecular and Cellular Biology|September 16, 2004
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivityM Stacey Ricci, Zhaoyu Jin, Michael Dews, et al.
Molecular Cancer|May 1, 2015
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cellsElizabeth M Matthew, Timothy J Yen, David T Dicker, et al.
Molecular Cancer|October 18, 2024
Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Pageof 10